Editor’s note: This interview has been edited for length and clarity.

Zoetis Inc. (NYSE:ZTS) is one of the 10 Worst Aggressive Growth Stocks to Buy According to Short Sellers. On June 18, Stifel ...

Infosys partners with Zoetis to enhance digital capabilities in animal health industry, focusing on AI solutions and ...

I remain positive on Phibro's long-term prospects and would look to buy on dips, as structural improvements appear ...

Infosys is expected to improve Zoetis’ operational efficiency and help the former with its long-term business objectives.

Markets saw a volatile session on Tuesday as it tracked the developments in the Middle East. The benchmark indices showed ...

Services, JB Chemicals and Pharmaceuticals, Aurobindo Pharma, Timex Group India, Infosys, Hindalco Industries, Bajel Projects ...

Nick Jorgensen breaks down how genomics testing helps cattle producers select better heifers, manage risk, reduce bull ...

The generic drug contains cefovecin sodium, the same active ingredient as Convenia (Zoetis), which was approved by the FDA in ...

Infosys has announced a strategic partnership with Zoetis to enhance the latter's IT operations using AI and automation. This ...

Shares of Zoetis have moved 0.9% today, and are now trading at a price of $156.47. In contrast, the S&P 500 index saw a 0.0% ...

Fintel reports that on June 18, 2025, Stifel downgraded their outlook for Zoetis (NYSE:ZTS) from Buy to Hold. Analyst Price ...